Alkali Metals Limited (ALKALI METALS LTD.) aksje
ALKALI.BO
StengtALKALI METALS LTD.
Market Cap
$1,018,250,624
Om Alkali Metals Limited (ALKALI METALS LTD.) aksje
Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyridine n-oxide, pyrimidine, quinoline, tetrazole, and triazole compounds; azaindole, potassium, sodium, and other metal derivatives; boronic acids, and DSSC and OLED materials; and organic, inorganic, and fine chemicals. The company's products are used in pharma intermediates, anti retrovirals, flu vaccines, antibiotics, cardio/anti inflammation, agrochemicals, and automobiles applications. Alkali Metals Limited was incorporated in 1968 and is based in Hyderabad, India.
Selskapsinformasjon
500039 Hyderabad, India
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.